JENNIFER WILLIFORD: Open Payments
NPI 1508875477 · BATTLE CREEK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,200 in 69 payments from 16 companies in 2025. Trend: 2023 $1,530 · 2024 $1,962 · 2025 $3,200
Food & beverage: $1,659Consulting: $1,440Education: $101
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 3 | $1,493 |
| GENZYME CORPORATION | 9 | $308 |
| UCB, Inc. | 8 | $302 |
| Amgen Inc. | 10 | $255 |
| E.R. Squibb & Sons, L.L.C. | 2 | $189 |
| Janssen Biotech, Inc. | 5 | $148 |
| Organon LLC | 14 | $115 |
| Novartis Pharmaceuticals Corporation | 4 | $84 |
| Lilly USA, LLC | 4 | $82 |
| Galderma Laboratories, L.P. | 3 | $58 |
Products named: DUPIXENT, Bimzelx, Otezla, Sotyktu, TREMFYA, VTAMA, COSENTYX, EBGLYSS.
Industry payments across MI — which companies pay providers there.
